InspireMD (NYSE:NSPR) Stock Price Down 1.5% – Here’s Why

by · The Markets Daily

InspireMD, Inc. (NYSE:NSPR – Get Free Report) was down 1.5% during trading on Monday. The company traded as low as $0.67 and last traded at $0.6895. Approximately 23,494 shares traded hands during trading, a decline of 83% from the average session volume of 141,243 shares. The stock had previously closed at $0.70.

InspireMD Price Performance

The firm has a market cap of $32.05 million, a price-to-earnings ratio of -0.92 and a beta of 0.83. The business’s 50-day moving average price is $0.79 and its two-hundred day moving average price is $1.00.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Nantahala Capital Management LLC acquired a new position in InspireMD in the 2nd quarter valued at $2,363,876. Parkman Healthcare Partners LLC acquired a new stake in shares of InspireMD during the second quarter worth $1,692,000. BlackRock Inc. acquired a new stake in shares of InspireMD during the second quarter worth $86,000. Finally, Renaissance Technologies LLC purchased a new stake in shares of InspireMD in the first quarter valued at $29,000. 44.78% of the stock is currently owned by institutional investors and hedge funds.

InspireMD Company Profile

(Get Free Report)

InspireMD, Inc (NYSE:NSPR) is a medical device company focused on developing and commercializing products for the treatment of vascular disease. The company’s primary focus is carotid artery disease, a condition in which plaque buildup can restrict blood flow and increase the risk of stroke.

Its principal product is the CGuard Embolic Prevention System (EPS), a carotid stent system that combines a self-expanding stent with a fine mesh layer called MicroNet. The design is intended to stabilize plaque, reduce plaque protrusion through the stent, and help limit the release of embolic material during and after carotid artery procedures.

Featured Stories